ALSVID PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALSVID PHARMA
Largest movements
- Cash +€90,285
up €90,285 (+478%), from €18,894 to €109,179
mainly Debts after one year (+€53,487) and Receivables within one year (+€50,512)
- Receivables within one year -€50,512
down €50,512 (-37.1%), from €136,069 to €85,557
of which Trade receivables: -€51,884
- Stocks and contracts +€23,538
up €23,538 (+388%), from €6,071 to €29,609
- Tangible fixed assets +€9,821
new in 2025: €9,821
- Deferred charges and accrued income +€7,486
up €7,486 (+2,470%), from €303 to €7,789
- Debts after one year +€53,487
new in 2025: €53,487
- Trade debts -€22,247
down €22,247 (-31.6%), from €70,351 to €48,103
- Reserves +€22,127
up €22,127 (+89.7%), from €24,672 to €46,799
- Current portion of long-term debt +€16,458
new in 2025: €16,458
- Other debts +€11,389
up €11,389 (+16.0%), from €71,219 to €82,608
- Gross operating margin +€17,428
up €17,428 (+73.1%), from €23,840 to €41,268
- Taxes +€3,837
up €3,837 (+73.0%), from €5,256 to €9,092
- Financial charges +€3,326
up €3,326 (+121%), from €2,744 to €6,069
- Depreciation +€1,788
up €1,788 (+71.6%), from €2,497 to €4,285
- Financial income +€1,464
up €1,464 (+18,627%), from €8 to €1,472
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €181,837 | €261,182 | +€79,344 | +43.6% |
| Fixed assets | 21/28 | €20,486 | €29,048 | +€8,562 | +41.8% |
| Intangible fixed assets | 21 | €20,486 | €19,226 | -€1,259 | -6.1% |
| Tangible fixed assets | 22/27 | - | €9,821 | +€9,821 | |
| Furniture and vehicles | 24 | - | €9,821 | +€9,821 | |
| Current assets | 29/58 | €161,352 | €232,134 | +€70,782 | +43.9% |
| Stocks and contracts in progress | 3 | €6,071 | €29,609 | +€23,538 | +388% |
| Stocks | 30/36 | €6,071 | €29,609 | +€23,538 | +388% |
| Amounts receivable within one year | 40/41 | €136,069 | €85,557 | -€50,512 | -37.1% |
| Trade receivables | 40 | €135,830 | €83,947 | -€51,884 | -38.2% |
| Other amounts receivable | 41 | €239 | €1,610 | +€1,372 | +575% |
| Current investments | 50/53 | €15 | - | -€15 | |
| Cash at bank and in hand | 54/58 | €18,894 | €109,179 | +€90,285 | +478% |
| Deferred charges and accrued income | 490/1 | €303 | €7,789 | +€7,486 | +2,470% |
| Total equity and liabilities | 10/49 | €181,837 | €261,182 | +€79,344 | +43.6% |
| Equity | 10/15 | €27,172 | €49,299 | +€22,127 | +81.4% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €24,672 | €46,799 | +€22,127 | +89.7% |
| Distributable reserves | 133 | €24,672 | €46,799 | +€22,127 | +89.7% |
| Amounts payable | 17/49 | €154,665 | €211,882 | +€57,217 | +37.0% |
| Amounts payable after more than one year | 17 | - | €53,487 | +€53,487 | |
| Financial debts | 170/4 | - | €53,487 | +€53,487 | |
| Amounts payable within one year | 42/48 | €152,928 | €156,336 | +€3,409 | +2.2% |
| Current portion of amounts payable after more than one year | 42 | - | €16,458 | +€16,458 | |
| Trade debts | 44 | €70,351 | €48,103 | -€22,247 | -31.6% |
| Suppliers | 440/4 | €70,351 | €48,103 | -€22,247 | -31.6% |
| Taxes, remuneration and social security | 45 | €11,358 | €9,167 | -€2,191 | -19.3% |
| Taxes | 450/3 | €11,358 | €9,167 | -€2,191 | -19.3% |
| Other amounts payable | 47/48 | €71,219 | €82,608 | +€11,389 | +16.0% |
| Accrued charges and deferred income | 492/3 | €1,737 | €2,058 | +€321 | +18.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,497 | €4,285 | +€1,788 | +71.6% |
| Other operating charges | 640/8 | €872 | €1,166 | +€295 | +33.8% |
| Gross operating margin | 9900 | €23,840 | €41,268 | +€17,428 | +73.1% |
| Operating profit (loss) | 9901 | €20,471 | €35,817 | +€15,345 | +75.0% |
| Financial income | 75/76B | €8 | €1,472 | +€1,464 | +18,627% |
| Recurring financial income | 75 | €8 | €1,472 | +€1,464 | +18,627% |
| Financial charges | 65/66B | €2,744 | €6,069 | +€3,326 | +121% |
| Recurring financial charges | 65 | €2,744 | €6,069 | +€3,326 | +121% |
| Profit (loss) for the period before taxes | 9903 | €17,736 | €31,219 | +€13,484 | +76.0% |
| Income taxes | 67/77 | €5,256 | €9,092 | +€3,837 | +73.0% |
| Profit (loss) for the period | 9904 | €12,480 | €22,127 | +€9,647 | +77.3% |
| Profit (loss) for the period to be appropriated | 9905 | €12,480 | €22,127 | +€9,647 | +77.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.